CCS ASSOCIATES, INC.
Federal contractor profile
Total Awards
8
Total $
$19.9M
Top Agency
Department of Health and Human Services
NAICS Count
2
Total Awards
8
Total Obligated
$19.9M
Agencies Served
1
Expiring Contracts
4
Top Agencies
| Agency | Awards | Total Obligated |
|---|---|---|
| Department of Health and Human Services | 8 | $19.9M |
Top NAICS Codes
Expiring Contracts (4)
75N91023C00054337 days remaining
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING REQUIREMENT FOR REGULATORY SERVICES AND TECHNICAL
Department of Health and Human Services|Expires Sep 29, 2027
$12.4M
75N91023C00055337 days remaining
THE PURPOSE OF THE ACQUISITION IS TO PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS NECESSARY TO SUPPORT THE IDENTIFICATION, DEVELOPMENT, AND QUALIFICATION OF POTENTIAL CANCER PREVENTIVE AGENTS FOR INVESTIGATIONAL NE
Department of Health and Human Services|Expires Sep 29, 2027
$6.2M
75N95026F00001150 days remaining
REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. MARCH 27, 2026 TO MARCH 26, 2027
Department of Health and Human Services|Expires Mar 26, 2027
$335,910
75N95023P00692137 days remaining
MEDICAL WRITING CONSULTING SERVICES
Department of Health and Human Services|Expires Mar 13, 2027
$176,851.8
All Awards
SMALL BUSINESS SET ASIDE - TOTAL
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING REQUIREMENT FOR REGULATORY SERVICES AND TECHNICAL
Department of Health and Human Services75N91023C00054$12.4M
SMALL BUSINESS SET ASIDE - TOTAL
THE PURPOSE OF THE ACQUISITION IS TO PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS NECESSARY TO SUPPORT THE IDENTIFICATION, DEVELOPMENT, AND QUALIFICATION OF POTENTIAL CANCER PREVENTIVE AGENTS FOR INVESTIGATIONAL NE
Department of Health and Human Services75N91023C00055$6.2M
COST PLUS FIXED FEE
REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. APRIL 1, 2025 TO MARCH 31, 2026
Department of Health and Human Services75N95025F00001$394,539
REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. MARCH 27, 2026 TO MARCH 26, 2027
Department of Health and Human Services75N95026F00001$335,910
SMALL BUSINESS SET ASIDE - TOTAL
MEDICAL WRITING CONSULTING SERVICES
Department of Health and Human Services75N95023P00692$176,851.8
REGULATORY SUPPORT FOR LEAD GENE THERAPY CANDIDATES AS A TREATMENT FOR CONGENITAL MYASTHENIC SYNDROMES
Department of Health and Human Services75N98026F00001$159,115.55
SMALL BUSINESS SET ASIDE - TOTAL
MEDICAL WRITING CONSULTING AND DRUG DOSSIER DEVELOPMENT SUPPORT SERVICES
Department of Health and Human Services75N95020P00589$142,947.38
SMALL BUSINESS SET ASIDE - TOTAL
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Department of Health and Human Services75N95020P00601$130,621.48
Related insights
Spend by Year
Annual obligated spend trend